Q32 Bio (QTTB) EBITDA Margin Growth (3y) (2021 - 2023)
Q32 Bio (QTTB) EBITDA Margin Growth (3y) (2021 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 493,874.00 |
| Sep 30, 2023 | 456,695.00 |
| Jun 30, 2023 | 606,878.00 |
| Mar 31, 2023 | 595,594.00 |
| Dec 31, 2022 | 23,879.00 |
| Sep 30, 2022 | 299,728.00 |
| Jun 30, 2022 | 360,642.00 |
| Mar 31, 2022 | 461,429.00 |
| Dec 31, 2021 | -250,602.00 |
| Sep 30, 2021 | -85,236.00 |
| Jun 30, 2021 | -43,483.00 |
| Mar 31, 2021 | 94,360.00 |